Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia

Daniel Casey

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

Neuroleptic (antipsychotic) drug-induced acute extrapyramidal syndromes (EPS) and the late onset tardive dyskinesia (TD) are the major side effects that limit the use of these highly efficacious agents. The appropriate strategy for controlling these side effects is based on the clinical presentations, pathophysiological mechanisms, and contributions of patient and treatment-related risk factors. New information about the mechanisms of action of neuroleptics and the long-term outcome of acute EPS and TD provide valuable insights into these syndromes. The most effective method for maximizing the benefits and minimizing the risks of neuroleptics is to use the lowest effective dose of both neuroleptic and antiEPS drugs in patients who benefit from them. The next major advancement will be to develop new compounds which effectively control psychotic symptoms and are free of the undesirable acute and tardive motor syndromes.

Original languageEnglish (US)
Pages (from-to)109-120
Number of pages12
JournalSchizophrenia Research
Volume4
Issue number2
DOIs
StatePublished - 1991

Fingerprint

Antipsychotic Agents
Tardive Dyskinesia
Therapeutics

Keywords

  • Extrapyramidal syndrome
  • Neuroleptic drug
  • Tardive dyskinesia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia. / Casey, Daniel.

In: Schizophrenia Research, Vol. 4, No. 2, 1991, p. 109-120.

Research output: Contribution to journalArticle

@article{73e5414086734c278d67e7b3366a30d3,
title = "Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia",
abstract = "Neuroleptic (antipsychotic) drug-induced acute extrapyramidal syndromes (EPS) and the late onset tardive dyskinesia (TD) are the major side effects that limit the use of these highly efficacious agents. The appropriate strategy for controlling these side effects is based on the clinical presentations, pathophysiological mechanisms, and contributions of patient and treatment-related risk factors. New information about the mechanisms of action of neuroleptics and the long-term outcome of acute EPS and TD provide valuable insights into these syndromes. The most effective method for maximizing the benefits and minimizing the risks of neuroleptics is to use the lowest effective dose of both neuroleptic and antiEPS drugs in patients who benefit from them. The next major advancement will be to develop new compounds which effectively control psychotic symptoms and are free of the undesirable acute and tardive motor syndromes.",
keywords = "Extrapyramidal syndrome, Neuroleptic drug, Tardive dyskinesia",
author = "Daniel Casey",
year = "1991",
doi = "10.1016/0920-9964(91)90029-Q",
language = "English (US)",
volume = "4",
pages = "109--120",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia

AU - Casey, Daniel

PY - 1991

Y1 - 1991

N2 - Neuroleptic (antipsychotic) drug-induced acute extrapyramidal syndromes (EPS) and the late onset tardive dyskinesia (TD) are the major side effects that limit the use of these highly efficacious agents. The appropriate strategy for controlling these side effects is based on the clinical presentations, pathophysiological mechanisms, and contributions of patient and treatment-related risk factors. New information about the mechanisms of action of neuroleptics and the long-term outcome of acute EPS and TD provide valuable insights into these syndromes. The most effective method for maximizing the benefits and minimizing the risks of neuroleptics is to use the lowest effective dose of both neuroleptic and antiEPS drugs in patients who benefit from them. The next major advancement will be to develop new compounds which effectively control psychotic symptoms and are free of the undesirable acute and tardive motor syndromes.

AB - Neuroleptic (antipsychotic) drug-induced acute extrapyramidal syndromes (EPS) and the late onset tardive dyskinesia (TD) are the major side effects that limit the use of these highly efficacious agents. The appropriate strategy for controlling these side effects is based on the clinical presentations, pathophysiological mechanisms, and contributions of patient and treatment-related risk factors. New information about the mechanisms of action of neuroleptics and the long-term outcome of acute EPS and TD provide valuable insights into these syndromes. The most effective method for maximizing the benefits and minimizing the risks of neuroleptics is to use the lowest effective dose of both neuroleptic and antiEPS drugs in patients who benefit from them. The next major advancement will be to develop new compounds which effectively control psychotic symptoms and are free of the undesirable acute and tardive motor syndromes.

KW - Extrapyramidal syndrome

KW - Neuroleptic drug

KW - Tardive dyskinesia

UR - http://www.scopus.com/inward/record.url?scp=0025975251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025975251&partnerID=8YFLogxK

U2 - 10.1016/0920-9964(91)90029-Q

DO - 10.1016/0920-9964(91)90029-Q

M3 - Article

VL - 4

SP - 109

EP - 120

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 2

ER -